Medirom Healthcare Technologies (MRM) Stock Price, News & Analysis

Company Overview

MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. As of December 31, 2021, this segment operated 312 relaxation salons under the Re.Ra.Ku and Ruam Ruam brand. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, its internally developed on-demand health monitoring smartphone application; MOTHER Tracker for fitness applications; and preventative healthcare services utilizing its digital application and devices. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques located in the Odaiba area in Tokyo. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Key Stats

• Today's Range: $0.91 to $0.96
• 50-Day Range: $0.91 to $1.35
• 52-Week Range: $0.72 to $4.45
• Volume: 34,255 shs
• Average Volume: 27,811 shs
• Market Capitalization: $25.83 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Medirom Healthcare Technologies Stock Analysis - MarketRank™

Medirom Healthcare Technologies scored higher than 17% of companies evaluated by MarketBeat, and ranked 47th out of 53 stocks in the services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Medirom Healthcare Technologies has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Medirom Healthcare Technologies has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Medirom Healthcare Technologies has a P/B Ratio of 3.96. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.53% of the float of Medirom Healthcare Technologies has been sold short.

Short Interest Ratio / Days to Cover

Medirom Healthcare Technologies has a short interest ratio ("days to cover") of 3.87, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medirom Healthcare Technologies has recently decreased by 2.37%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Medirom Healthcare Technologies does not currently pay a dividend.

Dividend Growth

Medirom Healthcare Technologies does not have a long track record of dividend growth.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: N/A

News Sentiment

Medirom Healthcare Technologies has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Services companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Medirom Healthcare Technologies this week, compared to 1 article on an average week.

MarketBeat Follows

4 people have added Medirom Healthcare Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Medirom Healthcare Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

40.24% of the stock of Medirom Healthcare Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Medirom Healthcare Technologies has minimal institutional ownership at this time.

Company Calendar

• Today: 5/15/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Services
• Industry: Services – Personal
• Sub-Industry: Personal Services
• Current Symbol: NASDAQ:MRM
• Previous Symbol: NYSE:MRM
• CIK: 1819704
• Web: N/A
• Phone: 81-3-6721-7364
• Fax: N/A
• Employees: 1,051
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $8.07 billion
• Price / Sales: 0.00
• Cash Flow: $0.10 per share
• Price / Cash Flow: 9.40
• Book Value: $0.23 per share
• Price / Book: 3.96

Miscellaneous

• Outstanding Shares: 28,387,000
• Free Float: 16,964,000
• Market Cap: $25.83 million
• Optionable: N/A
• Beta: 1.02